Fenofibrate just as good for women with diabetes as for men

The researchers from the universities of Sydney, Queensland and Melbourne said their findings should allay concerns about the use of fenofibrate in women raised by the ACCORD study, which suggested women may not gain benefit from the drug with regard to cardiovascular event reduction.